Mind the gap—the use of sodium fluoresceine for resection of brain metastases to improve the resection rate - Takeaways - MDSpire

Mind the gap—the use of sodium fluoresceine for resection of brain metastases to improve the resection rate

  • By

  • Johannes Kerschbaumer

  • Matthias Demetz

  • Aleksandrs Krigers

  • Daniel Pinggera

  • Antonio Spinello

  • Claudius Thomé

  • Christian F. Freyschlag

  • November 11, 2022

  • 0 min

Share

  • 1

    Brain metastases are the most common intracranial tumors, significantly affecting patients' quality of life.

  • 2

    Surgical resection of brain metastases can improve overall survival and reduce neurological deficits.

  • 3

    Sodium fluoresceine enhances visualization of tumors during surgery, potentially increasing the extent of resection.

  • 4

    The study aims to evaluate the impact of fluoresceine on postoperative outcomes and the accuracy of surgeons' resection estimates.

  • 5

    Seventy-nine patients were included, with fluoresceine used in 67% of cases, indicating its growing role in surgical procedures.

Original Source(s)

Mind the gap—the use of sodium fluoresceine for resection of brain metastases to improve the resection rate

  • by Johannes Kerschbaumer, Matthias Demetz, Aleksandrs Krigers, Daniel Pinggera, Antonio Spinello, Claudius Thomé, Christian F. Freyschlag

  • November 11, 2022

Related Content

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.

Impact of onset timing and operative duration on outcomes in chronic subdural hematoma: an exploratory retrospective study

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.

  • by

  • May 21, 2026

  • 1 min